ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
33.12B
Market cap33.12B
Price-Earnings ratio
22.53
Price-Earnings ratio22.53
Dividend yield
1.02%
Dividend yield1.02%
Average volume
1.06M
Average volume1.06M
High today
$230.15
High today$230.15
Low today
$225.00
Low today$225.00
Open price
$227.93
Open price$227.93
Volume
786.54K
Volume786.54K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

ResMed(RMD) stock is priced at $225.00, giving the company a market capitalization of 33.12B. It carries a P/E multiple of 22.53 and pays a dividend yield of 1.0%.

On 2026-03-20, ResMed(RMD) stock traded between a low of $225.00 and a high of $230.15. Shares are currently priced at $225.00, which is 0.0% above the low and -2.2% below the high.

The ResMed(RMD)'s current trading volume is 786.54K, compared to an average daily volume of 1.06M.

In the last year, ResMed(RMD) shares hit a 52-week high of $293.81 and a 52-week low of $199.92.

In the last year, ResMed(RMD) shares hit a 52-week high of $293.81 and a 52-week low of $199.92.

RMD News

Nasdaq 10h
Vulcan Materials Now #260 Largest Company, Surpassing ResMed

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Vulcan Materials Co (Symbol: VMC) has taken over the #2...

Vulcan Materials Now #260 Largest Company, Surpassing ResMed
Simply Wall St 12h
ResMed Is Down 5.1% After Market Value Slides Despite Solid Fundamentals Has The Bull Case Changed?

In the past week, ResMed’s share price weakness has erased about US$3.30 billion from its market value, leaving the company at roughly US$34.00 billion despite...

ResMed Is Down 5.1% After Market Value Slides Despite Solid Fundamentals Has The Bull Case Changed?
Simply Wall St 3d
Assessing ResMed Valuation After CEO Share Sale And Sector Pressures

ResMed (RMD) is back in focus after CEO Michael Farrell sold about US$1.25 million of stock under a pre arranged trading plan. This move coincided with a 2% sha...

Assessing ResMed Valuation After CEO Share Sale And Sector Pressures

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
24.1%
Sell
3.4%

More RMD News

TipRanks 4d
ResMed CEO Farrell Exercises Options and Sells Shares Under 10b5-1 Plan

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement. ResMed chairman and chief executive Michael...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.